Plain-English translation of NCT07602504 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — a large database being built across hospitals in China to collect medical information from patients whose cancer has spread to the liver. Researchers will gather details about your diagnosis, treatments you've received, and how you respond to care. The goal is to understand patterns in how metastatic liver cancer develops and progresses, so doctors can make better treatment decisions for future patients.
Right now, doctors don't have enough real-world data about what happens to patients with cancer that has spread to the liver — which treatments work best, who responds well, and what factors predict outcomes. This database will help fill that gap and lead to better, evidence-based care for everyone with this condition.
You likely qualify if…
You likely don't qualify if…
You would not receive any new medication or undergo new procedures as part of this study. Instead, researchers would access your existing medical records and collect information about your diagnosis, any treatments you've had, and your outcomes over time. You may be asked to complete follow-up visits or provide updated information about your health, but this is primarily a data-sharing study designed to help doctors learn from your care experience.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China